By evaluating the methylation status of the p16 gene between patients, Chao and co-workers found that hypermethylation of the p16 gene was highly correlated with inhibition of p16 gene transcription, which was associated with the progression of endometrial carcinoma [71]. This evidence concerns the gene CDKN2A and endometrial carcinoma.